near significancep = 0.0767
Interestingly, there was a near significance in improved overall survival comparing patients who received neoadjuvant chemotherapy with bevacizumab ( p = 0.0767, Figure 3 ).
Interestingly, there was a near significance in improved overall survival comparing patients who received neoadjuvant chemotherapy with bevacizumab ( p = 0.0767, Figure 3 ).
There was a trend towards significance when comparing the OS of patients who received neoadjuvant chemotherapy + Bevacizumab ( p = 0.0767) with dHGP patients exhibiting improved overall survival compared with non-dHGP patients ( Figure 3 D).